Skip to search formSkip to main contentSkip to account menu

elbasvir

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Objective : To determine the effectiveness of the treatment of chronic hepatitis C determined as the sustained viral response at… 
2018
2018
  • 2018
  • Corpus ID: 261131658
Recommended and alternative regimens listed by evidence level and alphabetically for: Treatment-Naive Patients Genotype 1b… 
2017
2017
The aim of the study is to develop and validate a simple, accurate, precise and rapid isocratic reverse-phase high-performance… 
2017
2017
Die Fixdosis-Kombination aus dem NS5A-Inhibitor Elbasvir und dem Protease-Inhibitor Grazoprevir mit und ohne Ribavirin konnte bei… 
2016
2016
A fixed oral dose combination of grazoprevir and elbasvir is used for the treatment of patients with genotypes 1&4 HCV infections… 
Review
2016
Review
2016
ABSTRACT Introduction: The combination of elbasvir and grazoprevir in a single co-formulated tablet is highly effective for… 
2016
2016
Patients taking ARAs and PPIs were also excluded from phase 2 and 3 studies of the HCV regimen containing the NS3/4A protease… 
Review
2016
Review
2016
Recent evidence has been accumulated showing a negative impact of chronic hepatitis C virus infection on survival in patients… 
2016
2016
  • Red.
  • 2016
  • Corpus ID: 195342824
_ In den meisten westlichen Ländern gilt intravenöser Drogenkonsum als Hauptrisikofaktor für eine Infektion mit dem Hepatitis-C… 
2015
2015
Bonn University Hospital, Bonn, Germany (Prof J K Rockstroh MD); Chelsea and Westminster Hospital, London, UK (M Nelson MD…